Rising Incidence Of Infectious Disorders Driving Growth In ELISA Testing Market: Powering Innovation and Expansion in the Enzyme-Linked Immunosorbent Assay Testing Market by 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Enzyme-Linked Immunosorbent Assay Testing Market Through 2025?
The market size for enzyme-linked immunosorbent assay (ELISA) testing has seen significant growth in the recent past. It's predicted to rise from $2.85 billion in 2024 to $3.04 billion in 2025, marking a compound annual growth rate (CAGR) of 6.7%. The expansion during the historic period can be traced back to an array of factors, including the widespread nature of chronic illnesses, increased investment in and focus on biomedical investigation, the approval of ELISA screenings by regulatory authorities, government-led initiatives, and programs aimed at enhancing health literacy.

What's the Projected Size of the Global Enzyme-Linked Immunosorbent Assay Testing Market by 2029?
In the upcoming years, the market size of the enzyme-linked immunosorbent assay testing is projected to witness robust growth, with an expected value of $3.88 billion by 2029, showcasing a compound annual growth rate (CAGR) of 6.3%. The growth progression in the subsequent forecast period is a result of increasing interest in personalized medicine, a rise in the aging population, a stronger focus on early diagnosis, enhanced access to healthcare services, and the escalating requirement for monitoring chronic diseases. The forecast period is also projected to observe significant trends such as technological innovations, an amplified demand for point-of-care testing, expanding areas of application, the preference for high-throughput screening, and the budding emergence of digital ELISA.

View the full report here:
https://www.thebusinessresearchcompany.com/report/enzyme-linked-immunosorbent-assay-testing-global-market-report

Top Growth Drivers in the Enzyme-Linked Immunosorbent Assay Testing Industry: What's Accelerating the Market?
Rising occurrences of infectious illnesses are anticipated to boost the expansion of the enzyme-linked immunosorbent assay testing market. These are ailments brought on by disease-producing microorganisms like viruses, bacteria, fungi, or parasites, that can spread among people, affecting various bodily systems. Increased global travel and the growing resistance to antimicrobials, which complicates infection management, are contributing to the escalating incidence of these disorders. Enzyme-linked immunosorbent assay (ELISA) testing is beneficial for identifying these disorders as it allows precise detection and measurement of specific antigens or antibodies linked to the infection, which aids in diagnosing, monitoring disease development, and evaluating the effectiveness of treatment. As an example, the World Health Organization, a Swiss-based international public health institution, reported a total of 58114 measles cases (a highly contagious viral disease) within the European Region in 2023, a notable increase from the 941 cases reported in 2022. Consequently, the rising occurrence of infectious illnesses is fuelling the expansion of the enzyme-linked immunosorbent assay testing market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19417&type=smp

What Trends Will Shape the Enzyme-Linked Immunosorbent Assay Testing Market Through 2029 and Beyond?
Key players in the enzyme-linked immunosorbent assay testing market are expanding their product range with innovative solutions, such as cutting-edge enzyme-linked immunosorbent assay (ELISA) kits, to advance diagnostic precision and cater to various research and clinical requirements. These new-generation Enzyme-Linked Immunosorbent Assay (ELISA) kits are enhanced versions of ELISA tests designed for increased accuracy, sensitivity, and user-friendliness in identifying and quantifying biomarkers. For example, Charles River Laboratories, a US pharmaceutical firm, unveiled a groundbreaking enzyme-linked immunosorbent assay (ELISA) kit in February 2023, aimed at determining and quantifying residual host cell proteins (HCP) in CHO-based biotherapeutics. This ground-breaking kit employs avian immunoglobulin Y (IgY) antibodies procured from specific pathogen-free (SPF) chicken eggs, delivering superior sensitivity, specificity, and detection thresholds as low as 0.1 ng/mL as well as 90% antibody coverage. By introducing this product, the intention is to enhance the quality control process in biopharmaceutical development, ensuring the safety and effectiveness of new treatments and offering flexibility for clients to use it independently or with assistance from Charles River's specialists.

What Are the Main Segments in the Enzyme-Linked Immunosorbent Assay Testing Market?
The enzyme-linked immunosorbent assay testingmarket covered in this report is segmented -

1) By Type: Direct Enzyme-Linked Immunosorbent Assay (ELISA), Sandwich Enzyme-Linked Immunosorbent Assay (ELISA), Indirect Enzyme-Linked Immunosorbent Assay (ELISA), Multiple And Portable Enzyme-Linked Immunosorbent Assay (ELISA), Competitive Enzyme-Linked Immunosorbent Assay (ELISA)
2) By Application: Immunology, Inflammation, Infectious Diseases, Cancer, Protein Quantitation, Other Applications
3) By End-User: Hospitals And Diagnostic Centers, Research Laboratories, Other End-Users

Subsegments:
1) By Direct Enzyme-Linked Immunosorbent Assay (ELISA): Single-Step Direct ELISA, Competitive Direct ELISA, Quantitative Direct ELISA, Qualitative Direct ELISA
2) By Sandwich Enzyme-Linked Immunosorbent Assay (ELISA): Two-Step Sandwich ELISA, One-Step Sandwich ELISA, Quantitative Sandwich ELISA, Qualitative Sandwich ELISA
3) By Indirect Enzyme-Linked Immunosorbent Assay (ELISA): Standard Indirect ELISA, Competitive Indirect ELISA, Quantitative Indirect ELISA, Qualitative Indirect ELISA

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=19417&type=smp

Which Top Companies are Driving Growth in the Enzyme-Linked Immunosorbent Assay Testing Market?
Major companies operating in the enzyme-linked immunosorbent assay testing market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Tecan Group Ltd., GenScript Biotech Corporation, Promega Corporation, Abcam plc, R&D Systems Inc., Sino Biological Inc., OriGene Technologies Inc., RayBiotech Inc., Santa Cruz Biotechnology Inc., AnaSpec Inc., Biomatik, Arigo Biolaboratories Corp., MyBioSource Inc., Boster Biological Technology, Eagle Biosciences Inc., Enzo Life Sciences Inc., StressMarq Biosciences Inc., XpressBio

Which Regions Will Dominate the Enzyme-Linked Immunosorbent Assay Testing Market Through 2029?
North America was the largest region in the enzyme-linked immunosorbent assay testing market in 2024. The regions covered in the enzyme-linked immunosorbent assay testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19417

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email: info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.